Myopia Needs You

Myopia is a significant problem and opportunity that cannot be ignored. Eye care practitioners have an obligation to collectively work together to do what’s best for their patients with progressive myopia. To quote Dr. Brien Holden, “We don’t know everything about myopia, but we know too much to do nothing.” MiSight® 1 day contact lenses are the first and only FDA-approved* soft contact lenses that go beyond correcting vision to help slow the progression of myopia in children aged 8-12 at the initiation of treatment [1]**. Come learn about the Brilliant Futures Myopia Management Program and see the six year results of the pivotal MiSight 1 day clinical trial.

* MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to 4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
1. Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. 2019;96(8):556-567. doi:10.1097/OPX.0000000000001410
** Compared to a single vision 1 day lens over a 3 year period.

Sponsored by:  CooperVision